title: Regulators can challenge deals that delay generic competition, says US Supreme Court.
authors.forename: Michael
authors.initials: M
authors.lastname: McCarthy
mesh_terms: D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic / Q000191:economics*; D004465:Economic Competition / Q000331:legislation & jurisprudence*; D006801:Humans; D035521:Supreme Court Decisions; D014481:United States
chemical_list: D016568:Drugs, Generic